Thrombolytic Therapy for Acute Ischaemic Stroke: What Can We Do to Improve Outcomes?

ISSN： 0012-6667

Source： Drugs, Vol.72, Iss.14, 2012-10, pp. : 1833-1845

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimal Timing of Thrombolytic Therapy in Acute Ischaemic Stroke

By Madden K.

CNS Drugs, Vol. 16, Iss. 4, 2002-01 ,pp. : 213-218

Adis International

Access to resources Recommend Favorite

Prevention and Pharmacovigilance: What Should We Do, What Can We Do?

By Edwards I. Ralph

Drug Safety, Vol. 35, Iss. 2, 2012-02 ,pp. : 87-90

Adis International

Access to resources Recommend Favorite

Thrombolysis in the Treatment of Acute Ischaemic Stroke: What are the Likely Pharmacoeconomic Consequences?

By Lindsberg P.J. Roine R.O. Kaste M.

CNS Drugs, Vol. 14, Iss. 1, 2000-07 ,pp. : 1-9

Adis International

Access to resources Recommend Favorite

Novel Thrombolytic Drugs: Will They Make a Difference in the Treatment of Ischaemic Stroke?

By Meretoja Atte Tatlisumak Turgut

CNS Drugs, Vol. 22, Iss. 8, 2008-01 ,pp. : 619-629

Adis International

Access to resources Recommend Favorite

Clinical Potential of Intra-Arterial Thrombolytic Therapy in Patients with Acute Ischaemic Stroke

By Xavier A.R.

CNS Drugs, Vol. 17, Iss. 4, 2003-01 ,pp. : 213-224

Adis International

Access to resources Recommend Favorite